2022-002325-99
Adipose derived mesenchymal stem cells as local treatment of ulcerative colitis
Aarhus University Hospital·EU Clinical Trials RegisterOngoing
Study focus
- Disease/Condition
- Ulcerative colitis
Sponsor & location
- Primary sponsor
- Aarhus University Hospital
- Funder
- Innovationsfonden
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
Reduceret inflammatorisk aktivitet vurderet med endoskopisk Mayoscore (bilag 1) 14 dage efter behandling med injektion af allogene fedtderiverede mesenkymale stamceller.
ICD-10 classifications
Ulcerative colitisOther ulcerative colitisUlcerative colitis, unspecifiedArthropathy in ulcerative colitisJuvenile arthritis in ulcerative colitis
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2022-002325-99
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2022-002325-99 through Pure Global AI's free database. This phase not specified trial is sponsored by Aarhus University Hospital and is currently Ongoing. The study focuses on Ulcerative colitis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.